Skip to main content
. 2017 Mar 21;42(4):1254–1266. doi: 10.1007/s11064-016-2167-7

Fig. 7.

Fig. 7

Mouse embryonic NSCs were treated with 1 mM VPA for up to 7 days in the absence or presence of 10 µM SP600125 and immunostained with anti-β-tubulin-III, anti-MAP-2, anti-CNPase, and anti-GFAP. Scale bar 100 μm